The market for senior talent across life sciences technology has rarely been tighter. Demand has shifted faster than supply, and the leaders who can turn scientific ambition into commercial outcomes are in short supply, and high demand.
After two years of cautious hiring, the market is seeing renewed investment across pharma-tech, clinical software, real-world data and AI-enabled services. But the recovery is uneven. Companies are not hiring more of everything; they are hiring differently, concentrating budget on a narrow band of roles that move revenue, de-risk delivery, or unlock a technology advantage.
Three categories are absorbing the majority of senior search activity. Commercial leadership sits at the top: CCOs, VPs of Sales and market-access leaders who can scale revenue in complex, regulated buying environments. AI, data and analytics follows closely, as organisations move from pilots to production and need leaders who can build capability rather than commission projects. And regulatory and quality technology remains structurally undersupplied, with demand outpacing the available pool of experienced leaders.
“The scarcest profile today is the leader who is equally fluent in the science, the software and the sale.”
The candidates clients most want are rarely on the open market. The strongest leaders are employed, performing, and not responding to job adverts. They move for a compelling mandate, the right backers, and a credible route to impact, not a marginal increase in salary. That reality is reshaping how hiring gets done: retained, mapped search is replacing reactive advertising, and speed of decision-making has become a genuine competitive advantage.
Employers who win in this market do three things well. They define success precisely before they go to market. They move quickly and decisively once the right person appears. And they treat the candidate experience as an extension of their brand, because the leaders they want are assessing them just as carefully.
Helping deliver talent that drives growth across the life sciences ecosystem.